Role of BRCA Mutations in the Modulation of Response to Platinum Therapy

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Role of P38-Mitogen-Activated Protein Kinase in Modulation of the Response to Therapy in FaDu Human Pharyngeal Carcinoma Cell

Romanian Biotechnological Letters
Applied MicrobiologyBiotechnologyAgronomyCrop ScienceGenetics
2019English

BRCA Mutations in the Manifestation and Treatment of Ovarian Cancer

Oncotarget
Oncology
2017English

The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy

Cancers
Cancer ResearchOncology
2019English

BRCA Mutations in Women With Inflammatory Breast Cancer

Cancer
Cancer ResearchOncology
2017English

The Role of Expression and Polymorphism of the BAG-1 Gene in Response to Platinum-Based Chemotherapeutics in NSCLC

Oncology Reports
MedicineCancer ResearchOncology
2011English

An Effective Epigenetic-Parp Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA-mutations

Clinical Cancer Research
Cancer ResearchOncology
2018English

Germline BRCA Mutation Does Not Prevent Response to Taxane-Based Therapy for the Treatment of Castration-Resistant Prostate Cancer

BJU International
Urology
2011English

Veliparib and Topotecan for Patients With Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer With BRCA Negative or Unknown BRCA Status

Cancer Treatment and Research Communications
Cancer ResearchOncology
2018English

The Contemporary Role of Echocardiography in Improving Patient Response to Cardiac Resynchronization Therapy

Current Cardiovascular Imaging Reports
Applied MicrobiologyBiotechnologyHistologyCell Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy